These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 16468471

  • 1. The evolving role of proteomics in the early detection of breast cancer.
    Pawlik TM, Kuerer HM.
    Int J Fertil Womens Med; 2005; 50(5 Pt 1):212-6. PubMed ID: 16468471
    [Abstract] [Full Text] [Related]

  • 2. Use of serological proteomic methods to find biomarkers associated with breast cancer.
    Rui Z, Jian-Guo J, Yuan-Peng T, Hai P, Bing-Gen R.
    Proteomics; 2003 Apr; 3(4):433-9. PubMed ID: 12687611
    [Abstract] [Full Text] [Related]

  • 3. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.
    Lai TC, Chou HC, Chen YW, Lee TR, Chan HT, Shen HH, Lee WT, Lin ST, Lu YC, Wu CL, Chan HL.
    J Proteome Res; 2010 Mar 05; 9(3):1302-22. PubMed ID: 20052998
    [Abstract] [Full Text] [Related]

  • 4. Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid.
    Li J, Zhao J, Yu X, Lange J, Kuerer H, Krishnamurthy S, Schilling E, Khan SA, Sukumar S, Chan DW.
    Clin Cancer Res; 2005 Dec 01; 11(23):8312-20. PubMed ID: 16322290
    [Abstract] [Full Text] [Related]

  • 5. Proteomics for the identification of new prostate cancer biomarkers.
    Ornstein DK, Tyson DR.
    Urol Oncol; 2006 Dec 01; 24(3):231-6. PubMed ID: 16678055
    [Abstract] [Full Text] [Related]

  • 6. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
    Ou K, Yu K, Kesuma D, Hooi M, Huang N, Chen W, Lee SY, Goh XP, Tan LK, Liu J, Soon SY, Bin Abdul Rashid S, Putti TC, Jikuya H, Ichikawa T, Nishimura O, Salto-Tellez M, Tan P.
    J Proteome Res; 2008 Apr 01; 7(4):1518-28. PubMed ID: 18318472
    [Abstract] [Full Text] [Related]

  • 7. Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer.
    Jones MB, Krutzsch H, Shu H, Zhao Y, Liotta LA, Kohn EC, Petricoin EF.
    Proteomics; 2002 Jan 01; 2(1):76-84. PubMed ID: 11788994
    [Abstract] [Full Text] [Related]

  • 8. Identification of distinct protein expression patterns in bilateral matched pair breast ductal fluid specimens from women with unilateral invasive breast carcinoma. High-throughput biomarker discovery.
    Kuerer HM, Goldknopf IL, Fritsche H, Krishnamurthy S, Sheta EA, Hunt KK.
    Cancer; 2002 Dec 01; 95(11):2276-82. PubMed ID: 12436432
    [Abstract] [Full Text] [Related]

  • 9. Identification of protein clusters predictive of response to chemotherapy in breast cancer patients.
    Cortesi L, Barchetti A, De Matteis E, Rossi E, Della Casa L, Marcheselli L, Tazzioli G, Lazzaretti MG, Ficarra G, Federico M, Iannone A.
    J Proteome Res; 2009 Nov 01; 8(11):4916-33. PubMed ID: 19739612
    [Abstract] [Full Text] [Related]

  • 10. Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein.
    Pawlik TM, Hawke DH, Liu Y, Krishnamurthy S, Fritsche H, Hunt KK, Kuerer HM.
    BMC Cancer; 2006 Mar 16; 6():68. PubMed ID: 16542425
    [Abstract] [Full Text] [Related]

  • 11. High-throughput genomic technology in research and clinical management of breast cancer. Plasma-based proteomics in early detection and therapy.
    Davis MA, Hanash S.
    Breast Cancer Res; 2006 Mar 16; 8(6):217. PubMed ID: 17184556
    [Abstract] [Full Text] [Related]

  • 12. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
    Zhang GQ, Du J, Pang D.
    Zhonghua Zhong Liu Za Zhi; 2006 Mar 16; 28(3):204-7. PubMed ID: 16875606
    [Abstract] [Full Text] [Related]

  • 13. Proteomics of breast carcinoma.
    Somiari RI, Somiari S, Russell S, Shriver CD.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb 05; 815(1-2):215-25. PubMed ID: 15652811
    [Abstract] [Full Text] [Related]

  • 14. Clinical proteomics in breast cancer: a review.
    Gast MC, Schellens JH, Beijnen JH.
    Breast Cancer Res Treat; 2009 Jul 05; 116(1):17-29. PubMed ID: 19082706
    [Abstract] [Full Text] [Related]

  • 15. Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients.
    El-Aneed A, Banoub J.
    Anticancer Res; 2006 Jul 05; 26(5A):3293-300. PubMed ID: 17094443
    [Abstract] [Full Text] [Related]

  • 16. [Proteomics and breast cancer].
    Mathelin C, Tomasetto C, Cromer A, Rio MC.
    Gynecol Obstet Fertil; 2006 Dec 05; 34(12):1161-9. PubMed ID: 17123853
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Proteome analysis of prostate cancer.
    Kuruma H, Egawa S, Oh-Ishi M, Kodera Y, Maeda T.
    Prostate Cancer Prostatic Dis; 2005 Dec 05; 8(1):14-21. PubMed ID: 15477873
    [Abstract] [Full Text] [Related]

  • 20. A proteomic approach to investigate potential biomarkers directed against membrane-associated breast cancer proteins.
    Canelle L, Bousquet J, Pionneau C, Hardouin J, Choquet-Kastylevsky G, Joubert-Caron R, Caron M.
    Electrophoresis; 2006 Apr 05; 27(8):1609-16. PubMed ID: 16550497
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.